U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 12b-25
NOTIFICATION OF LATE FILING

(Check One):

[  ]Form 10-K   [  ]Form 20-F   [  ]Form 11-K   [X]Form 10-Q   [  ]Form N-SAR

For Period Ended: April 30, 2011

[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:

Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.

If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates: N/A                              
 

Part I - Registrant Information
 
Full Name of Registrant:                                                                                                                                                    BioCube, Inc.
Former Name if Applicable:  N/A
Address of Principal Executive Office:
  1365 N. Courtenay Parkway, Suite A
(Street and Number)
Merritt Island, Fl 32953
(City, State and Zip Code)
  333-137920
40537K103
Commission File Number 
CUSIP Number
 
Part II - Rules 12b-25(b) and (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)

[X]  (a) The reasons described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense.

[X]  (b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and

(c) The accountant's statement or other exhibit required by Rule 12(b)-25(c) has been attached if applicable.


PART III - Narrative
 
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q, N-SAR, or the transition report or portion thereof could not be filed within the prescribed period.

The Registrant could not complete its Quarterly Report on Form 10-Q within 45 days of the fiscal year-end because the Registrant merged its subsidiaries into itself in December 2010 and the integration of the financial statements of the parent and the former subsidiaries could not be completed in time to file the Report on the due date.  In addition, certain convertible promissory notes owed by Registrant with beneficial conversion features have been amended and modified, which requires recalculation of the financial results. The Quarterly Report will be filed within 5 calendar days of the due date.
 
Part IV - Other Information

(1)  Name and telephone number of person to contact in regard to this notification:
  Boris Rubizhevsky
321-452-9091
(Name) (Area Code) (Telephone No.)
 
(2)           Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the Registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
 
[X] Yes   [  ] No

(3)           Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
 
[ ] Yes   [X] No

If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.

BioCube, Inc .
(Name of Registrant as specified in charter)

has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
 
     
       
Date: June 14, 2011
By:
/s/ Boris Rubizhevsky
 
   
Boris Rubizhevsky
 
   
Chief ExecutiveOfficer
 
       

BioCube (CE) (USOTC:BICB)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024 Click aqui para mais gráficos BioCube (CE).
BioCube (CE) (USOTC:BICB)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024 Click aqui para mais gráficos BioCube (CE).